XML 78 R62.htm IDEA: XBRL DOCUMENT v3.22.0.1
Subsequent Event - Additional Information (Details)
$ in Millions
1 Months Ended
Jan. 31, 2022
USD ($)
Subsequent Event [Line Items]  
Joint share 50.00%
Subsequent Event  
Subsequent Event [Line Items]  
Upfront payment $ 60.0
license and collaboration agreement Stoke Therapeutics, Inc.
Maximum | Subsequent Event  
Subsequent Event [Line Items]  
Milestone payments $ 907.5